
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: Market Cap wise it is among the top 20% companies of india.
Smart Money: Smart money has been increasing their position in the stock.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -11.8% return compared to 10.6% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -16.4% in last 30 days.
Valuation | |
|---|---|
| Market Cap | 5.82 kCr |
| Price/Earnings (Trailing) | 20.72 |
| Price/Sales (Trailing) | 1.14 |
| EV/EBITDA | 11.53 |
| Price/Free Cashflow | 38.99 |
| MarketCap/EBT | 16.55 |
| Enterprise Value | 5.75 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 5.11 kCr |
| Rev. Growth (Yr) | 27.6% |
| Earnings (TTM) | 280.82 Cr |
| Earnings Growth (Yr) | -8.7% |
Profitability | |
|---|---|
| Operating Margin | 7% |
| EBT Margin | 7% |
| Return on Equity | 11.08% |
| Return on Assets | 7.43% |
| Free Cashflow Yield | 2.56% |
Growth & Returns | |
|---|---|
| Price Change 1W | -8.6% |
| Price Change 1M | -16.4% |
| Price Change 6M | -31.8% |
| Price Change 1Y | -23.6% |
| 3Y Cumulative Return | -11.8% |
| 5Y Cumulative Return | -7% |
| 7Y Cumulative Return | 5.7% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -294.59 Cr |
| Cash Flow from Operations (TTM) | 420.51 Cr |
| Cash Flow from Financing (TTM) | -157.31 Cr |
| Cash & Equivalents | 265.04 Cr |
| Free Cash Flow (TTM) | 201.85 Cr |
| Free Cash Flow/Share (TTM) | 56.93 |
Balance Sheet | |
|---|---|
| Total Assets | 3.78 kCr |
| Total Liabilities | 1.24 kCr |
| Shareholder Equity | 2.53 kCr |
| Current Assets | 2.38 kCr |
| Current Liabilities | 1.13 kCr |
| Net PPE | 1.02 kCr |
| Inventory | 822.59 Cr |
| Goodwill | 3.22 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.05 |
| Debt/Equity | 0.08 |
| Interest Coverage | 11.3 |
| Interest/Cashflow Ops | 20.27 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 22 |
| Dividend Yield | 1.17% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Size: Market Cap wise it is among the top 20% companies of india.
Smart Money: Smart money has been increasing their position in the stock.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: Underperforming stock! In past three years, the stock has provided -11.8% return compared to 10.6% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -16.4% in last 30 days.
Investor Care | |
|---|---|
| Dividend Yield | 1.17% |
| Dividend/Share (TTM) | 22 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 79.2 |
Financial Health | |
|---|---|
| Current Ratio | 2.11 |
| Debt/Equity | 0.08 |
Technical Indicators | |
|---|---|
| RSI (14d) | 14.63 |
| RSI (5d) | 16.28 |
| RSI (21d) | 23.16 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Buy |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Buy |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Galaxy Surfactants's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the Q3 FY 2025-26 earnings call, Galaxy Surfactants Limited's management provided an optimistic outlook despite facing several headwinds. Key points from their outlook include:
Demand Recovery: The company expects incremental improvement in volumes for both Tier 1 and non-Tier 1 accounts in India, predicting double-digit volume growth in its specialty segment as it evolves from the tariff-related disruptions in the U.S.
Impact of Tariff Reduction: Following a reduction in reciprocal tariffs on Indian exports from 50% to 18%, management anticipates regaining competitive ground in the U.S. market. They expect existing customer projects to recover and new pipelines to open, reflecting positively on upcoming quarters.
Performance Metrics: Management reported a consolidated Q3 FY 26 EBITDA before exceptional items of INR 124 crores (INR 110 crores year-on-year increase), with EBITDA per metric ton improving to INR 20,156 compared to INR 17,527 previously.
Market Dynamics: In India, domestic volume growth for Q3 FY 26 was mid-single digits year-on-year, with Performance Surfactants exhibiting a decline of about 4% due to reformulation pressures, whereas the specialty segment saw a remarkable over 35% growth.
Product Innovations: The launch of five new products under the GalSORB and SunBliss range is expected to begin commercialization in Q4 FY 26, which could enhance the EBITDA profile due to higher margins associated with these premium products.
Operational Resilience: Management emphasized successful cost management initiatives, which continue to enhance margins despite ongoing challenges in raw material pricing and market competition.
In summary, Galaxy Surfactants Limited is poised for gradual recovery, with strategic initiatives aimed at capturing growth opportunities, particularly in specialty segments, amid a stabilizing tariff environment in the U.S. market.
1. Question: "On the AMET, we said that there's a competitive intensity, which has increased in Q3. What has changed just in a matter of a quarter, which is giving us confidence?"
Answer: "In Q4, we initiated discussions with new geographies and completed project pipelines that should contribute positively. While competition remains fierce, we have taken steps to strengthen our offerings, and I believe we will start seeing volume flow from these efforts in Q4."
2. Question: "On India, we were supposed to adopt the new changes in formulation with new product introduction. Where are we in that process?"
Answer: "We are nearly ready for the new formulation. However, key customers had paused progress due to GST adjustments. Approval is imminent and we expect the business impact to be felt significantly next fiscal year."
3. Question: "You said that the margin boost was due to the EPC segment. Can you give more detail on that?"
Answer: "Due to confidentiality agreements with customers, I can't disclose specific numbers. However, I can confirm that the impact on our year-to-date earnings has not been significant but has provided some positive contributions."
4. Question: "With the recent U.S. trade update, should we expect margin gains from tariff reductions?"
Answer: "While we mitigated some costs during high tariffs, we couldn't fully pass through burdens to customers. The tariff reduction strengthens our position to restore projects, allowing us to better structure future contracts for improved margins."
5. Question: "Can you give insights into customer strategies regarding reformulation? Will they revert back to previous formulations?"
Answer: "Reformulations initiated due to high prices typically lead to temporary adjustments. Once prices stabilize, I anticipate our customers will revert to original formulations. We project better conditions from May onward as feedstock prices normalize."
6. Question: "What is the expected double-digit growth for specialty segments"”is this for FY27 or beyond?"
Answer: "We expect double-digit growth in the specialty segment this fiscal and foresee this trajectory continuing. However, market conditions will play a significant role, especially as customers reevaluate contracts post-tariff adjustments."
7. Question: "On U.S. demand concerns, how do we manage these expectations?"
Answer: "The demand concerns flagged by major U.S. customers are new. While this may impact guidance, if favorable market conditions persist alongside tariff relief, we believe we can achieve our previous volume target of 6-8% over time."
8. Question: "When should we consider the impact of EPC revenue in future earnings guidance?"
Answer: "EPC revenue will be gradual and not significant in upcoming quarters due to the spread-out completion timeline. We don't anticipate any large impact on EBITDA from this segment in the near term."
9. Question: "How do changing raw material prices affect your EBITDA?"
Answer: "Volatility in raw material prices poses risks, but our risk management framework is robust. Minimal impact to EBITDA is expected even with price fluctuations, as we have planned our inventory cycles carefully based on market dynamics."
10. Question: "What share of our India business is influenced by reformulations?"
Answer: "The impact of reformulations fully reflects in Q3 numbers. Significant declines stemmed from customer reformulations, but we've experienced growth within Tier-2 and Tier-3 customers, somewhat offsetting these losses."
Understand Galaxy Surfactants ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Unnathan Shekhar | 11.92% |
| Shashikant Rayappa Shanbhag | 11.56% |
| Ramakrishnan Gopalkrishnan | 6.66% |
| Yash Sudhir Patil | 5.79% |
| Siddharth Sudhir Patil | 5.79% |
| Galaxy Chemicals, Partner Gopalkrishnan Ramakrishnan | 5.47% |
| Galaxy Chemicals, Partner Late Sandhya Sudhir Patil | 5.47% |
| Galaxy Chemicals, Partner Shashikant Rayappa Shanbhag | 5.47% |
| Galaxy Chemicals, Partner Shekhar Unnathan | 5.47% |
| Jayashree Ramakrishnan | 5.2% |
| Axis Mutual Fund | 4.38% |
| Nippon Life India | 3.83% |
| ICIC Prudential | 3.16% |
| Galaxy Emulsifiers Pvt Ltd | 1.53% |
| Jayshree Ramesh | 1.5% |
| Abu Dhabi Investment Authority - Monsoon | 1.44% |
| Icici Lombard General Insurance Company Ltd | 1.01% |
| Lakshmy Shekhar | 0.36% |
| Sridhar Unnathan | 0.1% |
| Vandana Shashikant Shanbhag | 0.03% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Galaxy Surfactants against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| VINATIORGA | Vinati Organics | 14.37 kCr | 2.31 kCr | -7.70% | -13.60% | 32.44 | 6.22 | - | - |
| FINEORG | Fine Organic Industries | 13.05 kCr | 2.46 kCr | -5.70% | +5.90% | 32.9 | 5.32 | - | - |
| BALAMINES | Balaji Amines | 3.46 kCr | 1.41 kCr | -3.30% | -14.90% | 24.12 | 2.45 | - | - |
Comprehensive comparison against sector averages
GALAXYSURF metrics compared to Chemicals
| Category | GALAXYSURF | Chemicals |
|---|---|---|
| PE | 20.72 | 41.13 |
| PS | 1.14 | 3.81 |
| Growth | 26.1 % | 7.2 % |
Galaxy Surfactants Limited manufactures and markets surfactants and other specialty ingredients in India and internationally. It offers fatty alcohol sulfates and ether sulfates, fatty alcohol ethoxylates and labsa, foam and viscosity boosters, mild surfactants, pearlizers, surfactant blends, syndets and TBB, sunscreens, functional actives, and preservatives and blends for personal care and home care products, including skin care, oral care, hair care, cosmetics, toiletries, and detergent products, as well as baby care, sun care, surface care, dishwash, and hand wash products. Galaxy Surfactants Limited was founded in 1980 and is based in Navi Mumbai, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
GALAXYSURF vs Chemicals (2021 - 2026)